Skip to content

Valiant Navion™ VNMF4640C185TU (UDI 00763000260682)Recalls & reported problems

Medtronic, Inc. · STENT GRAFT VNMF4640C185TU VAL NAV FF TP · Class 3 · Implant

All models of Valiant Navion (137)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
1
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00763000260682), received between Mar 5, 2021 and Dec 6, 2022 — classified as 1 death, 1 malfunction.

The most frequently reported specific device problem is “Leak/Splash” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Leak/Splash2

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Aneurysm1
  • Insufficient Information1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 6, 2022Leak/Splash; Adverse Event Without Identified Device or Use Problem; Leak/Splash; Adverse Event Without Identified Device or Use Problem

    VALIANT NAVION STENT GRAFTS WERE IMPLANTED AS PART OF A RE-INTERVENTION FOR A PRIOR AORTIC REPAIR .  IT WAS REPORTED ON THE DATE OF THE CT, THE SITE HAVE IDENTIFIED A TYPE IB ENDOLEAK.  NO CAUSE WAS REPORTED.  NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT WILL BE MONITORED.

    Patient problems: Aneurysm; No Clinical Signs, Symptoms or Conditions

    MAUDE report 15922707 ↗
  • DeathMar 5, 2021Leak/Splash; Adverse Event Without Identified Device or Use Problem; Leak/Splash; Adverse Event Without Identified Device or Use Problem

    VALIANT NAVION STENT GRAFTS WERE IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF AN 73MM SIZE THORACIC ANEURYSM. IT WAS REPORTED THAT APPROXIMATELY 2 DAYS LATER, A CT WAS PERFORMED WHERE AN ENDOLEAK WAS NOTED. AS PER THE PHYSICIAN THE CAUSE OF THE EVENT CAN NOT BE DETERMINED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT WILL BE MONITORED.

    Patient problems: Insufficient Information; No Clinical Signs, Symptoms or Conditions

    MAUDE report 11422768 ↗

Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices

All SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page